Targeting a systolic blood pressure (SBP) below 130 mmHg may significantly reduce hospitalizations in patients with heart failure with preserved ejection fraction (HFpEF), a recent systematic review ...

US biopharma Mineralys Therapeutics has announced positive topline data from its Phase II Explore-CKD trial evaluating the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

We often see heart attacks as sudden, dramatic events, often depicted on television. It shows someone clutching their chest, ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...